Oral atovaquone for the treatment of severe Pneumocystis jirovecii pneumonia in a patient with glucose-6-phosphate dehydrogenase deficiency

Scandinavian Journal of Infectious Diseases

Volumn 42, Issue 1, 2010, Pages 76-78

  Douzinas, Emmanuel E ^a   Flevari, Katerina ^a   Andrianakis, Ilias ^a   Betrosian, Alex P ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; CEFTRIAXONE; DEXAMETHASONE; GANCICLOVIR; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; MOXIFLOXACIN; PREDNISOLONE; TEMOZOLOMIDE; ANTIINFECTIVE AGENT;

ADULT; ARTICLE; CASE REPORT; COMMUNITY ACQUIRED PNEUMONIA; CYTOMEGALOVIRUS INFECTION; DRUG DOSE REDUCTION; DRUG INDICATION; DRUG SAFETY; FEMALE; GLIOBLASTOMA; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HUMAN; MIXED INFECTION; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; TREATMENT OUTCOME; DRUG EFFECT; GENETICS; MIDDLE AGED; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ANTI-INFECTIVE AGENTS; ATOVAQUONE; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GLUCOSEPHOSPHATE DEHYDROGENASE; HUMANS; MIDDLE AGED; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; TREATMENT OUTCOME;

EID: 77149165116     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365540903321606     Document Type: Article

References (15)

1. Phair J, Munoz A, Detels R, Kaslow R, Rinaldo C, Saah A. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group. N Engl J Med 1990;322:161-165
2. Varthalitis I, Aoun M, Daneau D, Meunier F. Pneumocystis carinii pneumonia in patients with cancer. An increasing incidence. Cancer 1993;71:481-485
3. Masur H. Prevention and treatment of Pneumocystis pneumonia. N Engl J Med 1992;327:1853-1860
4. Korraa H, Saadeh C. Options in the management of pneumonia caused by Pneumocystis carinii in patients with acquired immune deficiency syndrome and intol erance to trimethoprim/ sulphamethoxazole. South Med J 1996;89:272-277
5. Wazir JF, Ansari NA. Pneumocystis carinii infection. Update and review. Arch Pathol Lab Med 2004;128:1023-1027
6. Mahindra AK, Grossman SA. Pneumocystis carinii pneumonia in HIV negative patients with primary brain tumors. J Neurooncol 2003;63:263-270
7. Slivka A, Wen PY, Sheha WM. Pneumocystis carinii pneumonia during steroid taper in patients with primary brain tumors. Am J Med 1993;94:216-219
8. Russian DA, Levine SJ. Pneumocystis carinii pneumonia in patients without HIV infection. Am J Med Sci 2001;321: 56-65.
9. Bollee G, Sarfati C, Thiéry G, Bergeron A, de Miranda S, Menotti G, et al. Clinical picture of Pneumocystis jiroveci pneumonia in cancer patients. Chest 2007;132:1305-1310
10. Green H, Paul M, Vidal L, Leibovici L. Prophylaxis of Pneumocystis pneumonia in immunocompromised non- HIV-infected patients: systematic review and metaanalysis of randomized controlled trials. Mayo Clin Proc 2007;82:1052-1059
11. Baggish AL, Hill DR. Antiparasitic agent atovaquone. Antimicrob Agents Chemother 2002;46:1163-1173
12. Castro M. Treatment and prophylaxis of Pneumocystis carinii pneumonia. Sem Respir Infect 1998;13:296-303.
13. Ernst P, Chen MF, Wang NS, Cosio M. Symbiosis of Pneumocystis carinii and cytomegalovirus in a case of fatal pneumonia. Can Med Assoc J 1983;128:1089-1092
14. Gauthier JW, Sybers HD. Widely disseminated Pneumocystis carinii infection associated with cytomegalovirus pneumonitis. South Med J 1993;86:964-966
15. Gupta RJ, Naran S, Lallu S, Fauck R. Cytodiagnosis of simultaneous pulmonary infection due to cytomegalovirus and Pneumocystis carinii in a sample of bronchoalveolar lavage. Diagn Cytopathol 2004;30:341.